Showing 1 - 3 results of 3 for search 'Robert A Uger', query time: 0.02s Refine Results
  1. 1
    Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4<sup>+</sup> BTLA<sup>+</sup> T Cells in Tumor Microenvironment of Mycosis Fungoides

    Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4<sup>+</sup> BTLA<sup>+</sup> T Cells in Tumor Microenvironment of Mycosis... by Tony T. Jiang, Oleg Kruglov, Gloria H. Y. Lin, Angela Minic, Kimberly Jordan, Robert A. Uger, Mark Wong, Yaping Shou, Oleg E. Akilov

    Published 2021-11-01
    Get full text
    Article
  2. 2
    TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets.

    TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets. by Gloria H Y Lin, Vien Chai, Vivian Lee, Karen Dodge, Tran Truong, Mark Wong, Lisa D Johnson, Emma Linderoth, Xinli Pang, Jeff Winston, Penka S Petrova, Robert A Uger, Natasja N Viller

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition

    Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition by Hussein Al-Sudani, Ying Ni, Philip Jones, Huseyin Karakilic, Lei Cui, Lisa D. S. Johnson, Peter G. Rose, Alexander Olawaiye, Robert P. Edwards, Robert A. Uger, Gloria H. Y. Lin, Haider Mahdi

    Published 2023-07-01
    Get full text
    Article

Search Tools: